Antimicrobial (Drug) Resistance Quick Facts


Methicillin-Resistant Staphylococcus aureus bacteria

Scanning electron micrograph depicting methicillin-resistant Staphylococcus aureus bacteria with a human white cell.

  • Many infectious diseases are increasingly difficult to treat because of antimicrobial-resistant organisms, including HIV infection, staphylococcal infection, tuberculosis, influenza, gonorrhea, candida infection, and malaria.
  • Between 5 and 10 percent of all hospital patients develop an infection. About 90,000 of these patients die each year as a result of their infection, up from 13,300 patient deaths in 1992.
  • According to the Centers for Disease Control and Prevention (CDC) (April 2011), antibiotic resistance in the United States costs an estimated $20 billion a year in excess health care costs, $35 billion in other societal costs and more than 8 million additional days that people spend in the hospital.
  • People infected with antimicrobial-resistant organisms are more likely to have longer hospital stays and may require more complicated treatment.
  • The Antibiotic Resistance Threats in the United States, 2013 report from CDC gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.
Content last reviewed on